Expert Autologous Stem Cell Research | Biobanking Technologies | Quality Control Services
About Amplicell Medical
Amplicell Medical is a specialized biotechnology company with in-house R&D laboratory capabilities, focused on the preclinical development of
next-generation cellular therapeutics.
Based near Los Angeles, we uniquely focus on addressing cellular
and tissue damage associated with aging and age-related diseases.
Cell Therapy & Biobanking Innovation: We advance proprietary cell therapy programs and biobanking innovations through preclinical development, driving breakthroughs across regenerative and longevity medicine, with specific focus on dermatology, cardiology, and neurology.
Our Services
- Contract R&D and Manufacturing (for research only)
- Quality Control of Cellular Products
At Amplicell, we conduct preclinical research and development of autologous stem cell-based biologics, focusing on advancing technologies that enable rapid, personalized medical interventions by harnessing the body’s natural repair mechanisms and resources. Our vision is to integrate scientific innovation with rigorous regulatory compliance to develop next-generation solutions for age-related diseases and tissue/organ damage repair.
Important Notice: All therapeutic programs are in preclinical development. These products are for research use only and have not been approved by the FDA or other regulatory agencies for clinical use. No statements on this website have been evaluated by the FDA.
Our Mission
Become the catalyst for unleashing the adaptive regenerative
power of autologous stem cells.
Synergistically combine cell culture technologies, biobanking, and the rapid production of personalized medical interventions to unlock the transformational potential of autologous biologics.
Extend and improve lives
Our Team
Elena – Founder & Chief Scientific Officer
I'm a translational scientist dedicated to advancing regenerative medicine and cellular therapies with the goal of improving human health and extending healthy lifespan. My expertise spans regenerative medicine, stem cell research, biobanking, immunology, neurobiology, transplantology, molecular genetics, and microbiology. I hold an MD from Bogomolets National Medical University in Ukraine and a PhD in Immunology with subspecialty training in Cardiology. My 25+ year career includes research positions at Duke University, Harvard Medical School, UNC Chapel Hill, and the Gray Cancer Institute (now part of the University of Oxford), where I contributed to discoveries in immune regulation, cancer cell biology, ionizing radiation resistance, genetic neurodegenerative diseases, molecular genetics, and microbiology.
I'm driven by a deep belief in the body's innate capacity to heal. By harnessing the regenerative powers that evolution has already perfected within us, cutting-edge biomedical innovation guided by compassion and scientific integrity can transform how we treat age-related diseases.
Building on this research foundation, for more than five years I served as Chief Scientific Officer at cGMP stem cell bank, where I helped establish the facility and protocols for processing clinical-grade autologous MSCs and developing biologics. My expertise encompasses process development, clinical translation and regulatory compliance, with a particular focus on the safety and efficacy of cellular therapies.
Pavel - Director of Research
I'm a translational researcher and biomedical engineer dedicated to advancing targeted, image-guided technologies that are transforming tissue and disease treatment. I currently serve as an Assistant Professor at the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Hospital in Washington, DC.
My work focuses on developing advanced drug delivery systems and surgical innovations, particularly magnetic resonance imaging-guided high-intensity focused ultrasound (MR-HIFU). This novel technology integrates magnetic resonance imaging with therapeutic ultrasound to provide a completely noninvasive method for precise thermal ablation of targeted tissues with real-time imaging feedback.
I'm passionate about developing noninvasive, image-guided technologies that enhance the precision and impact of regenerative and biologic therapies—bringing us closer to safe, personalized treatment solutions.
Damian- Laboratory Management Advisor
I'm a laboratory management professional with extensive experience in establishing and developing clinical laboratories and tissue banks. I currently serve as Lead Laboratory Manager and Safety & Tissue Manager at University College London, where I oversee critical operations ensuring the highest standards of safety and quality.
My expertise encompasses laboratory safety protocols, regulatory compliance, and quality assurance for human tissue used in clinical and research applications. I specialize in developing robust systems that maintain tissue integrity while meeting stringent regulatory requirements for biobanking and clinical research.
I'm passionate about creating safe, compliant laboratory environments that enable groundbreaking research while protecting both personnel and the invaluable biological samples that drive medical advancement.